Could Covid vaccine be a catalyst for reversal of equity factors that perform best?

By Michael P. Regan The sun was just rising over New York on Nov. 9 when an announcement from Pfizer Inc. set in motion what would be one of this year’s heaviest days of volume in the US stock market — and one of the […]